Amogh I. Iyer

Amogh I. Iyer

Auto-generated profile, based on publicly available information

Amogh I. Iyer

College of Medicine, Ohio State University, Columbus, Ohio, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Journal of Urology
Verified
Journal Article
Closed access
PDF file
AMAkhil Muthigi
Akhil Muthigi
AGArvin George
Arvin George
DSDaniel Su
Daniel Su
PYPingkun Yan
Pingkun Yan
JKJochen Kruecker
Jochen Kruecker
PPPeter Pinto
Peter Pinto
Advances in multiparametric MRI combined with improved sampling by MR/TRUS fusion-guided prostate biopsy (FBx) have resulted in rapid adoption of this novel technology into the biopsy paradigm. FBx accuracy is dependent on a number of factors and acquired skills that vary by user experience. We aim to define the differences among users with varying levels of experience with a tracked fusion biopsy platform.

1 January 2025 in Advances in Orthopedics
Verified
Journal Article
Open access
JHJordan A. Haber
Jordan A. Haber
AIAmogh I. Iyer
Amogh I. Iyer
MDMatthew Dulas
Matthew Dulas
DWDouglas Weaver
Douglas Weaver
JSJason Strelzow
Jason Strelzow
Intramedullary nail fixation is the “gold standard” for surgical intervention of femoral fractures. While many aspects of nail design and patient anatomy have received specific focus, anatomic variations in proximal femoral geometry and greater trochanteric height variation have been poorly studied. Understanding the potential relationship of the greater trochanter to patient demographics may provide an opportunity to improve implant placement. Retrospective review of x‐ray and computed tomography images of the proximal femur was performed. Inclusion criteria consisted of skeletally mature patients over 18 years old with imaging of the proximal femur. Inclusion criteria identified 296 patients. Mean age of included patients was 34 ± 20 years. Average greater trochanter height was 40 ± 8.1 mm. Mean caput‐collum‐diaphyseal angle was 141 ± 8.6 degrees. After identifying significant factors using univariate analyses a multivariable linear regression demonstrated that patient height and caput‐collum‐diaphyseal angle were statistically significant predictors for greater trochanter height. For every 1 cm increase in patient height there was a predicted 0.11 mm increase in greater trochanter height ( p = 0.01). Conversely, every 1 degree increase in caput‐collum‐diaphyseal angle results in an associated 0.17 mm decrease in greater trochanter height ( p < 0.001). This study provides information that may allow for the potential optimization of implant design or implant position to minimize proximal nail protrusion, enhance nail fit and ensure cephalomedullary lag screw position in the head based on the proximal nail dimensions of the implant used.

1 June 2022 in Ophthalmic Surgery, Lasers and Imaging Retina
Verified
Journal Article
Closed access
AIAmogh I. Iyer
Amogh I. Iyer
JMJustin C Muste
Justin C Muste
AKAneesha Kalur
Aneesha Kalur
KTKatherine E. Talcott
Katherine E. Talcott
RSRishi P. Singh
Rishi P. Singh
To determine whether quantification of intraretinal fluid (IRF) and subretinal fluid (SRF) can be used as a biomarker for predicting visual prognosis in routine clinical practice. Retrospective, nonrandomized cohort study review of patients with neovascular age-related macular degeneration from January 1, 2012, to March 1, 2018. In the 286-patient cohort, the mean baseline, 6-month, and 12-month best-corrected visual acuity (BCVA) was 60.24 ± 18.63, 65.57 ± 16.56, and 65.61 ± 17.37 Early Treatment Diabetic Retinopathy Study (ETDRS) letters, respectively (P < .001). The regression coefficient in the linear mixed effects regression model quantifying the association between eyes in the fourth and first quartile of IRF and 12-month BCVA was −4.14 (95% CI, −6.65 to −1.63) (P = .001) ETDRS letters. The regression coefficient quantifying the association between eyes in the fourth and first quartile of SRF and 12-month BCVA was −0.7 (95% CI, −3.07 to 1.27) (P = .56) ETDRS letters. IRF and SRF are valuable biomarkers for BCVA outcomes in treatment-naïve neovascular age-related macular degeneration in routine clinical practice. [Ophthalmic Surg Lasers Imaging 2022;53:317–324.]